MedTrace Logo

Oral Health Education and Message Framing Effect on Oral Health Status of Refugees in Egypt

NCT06649760 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 510

Last updated 2024-10-21

No results posted yet for this study

Summary

Refugees, facing forced displacement and often exposed to traumatic experiences, represent a vulnerable population with unique healthcare needs. Oral health is considered a prominent factor that contributes to quality of life.

Therefore, this study aim at assessing the effect of message framing on enhancing oral health practices in a group of refugees in Alexandria, Egypt. A three-arm cluster randomized controlled clinical trial will compare a gain-framed mobile text messages group, a loss-framed mobile text messages group, and a control group. The primary outcome is the improvement in oral health practices measured by changes in dental plaque and secondary outcome is to assess change in oral health-related quality of life. In addition, oral health knowledge, attitudes, and practices of refugees will be assessed.

Conditions

  • Knowledge, Attitudes, Practice
  • Caries,Dental
  • Plaque, Dental
  • Gingivitis
  • Pocket, Periodontal

Interventions

BEHAVIORAL

Gain and loss framed mobile text messages

To assess the effect of message framing on enhancing oral health practices in a group of refugees

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mona El Kashlan, Professor · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-29
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06649760 on ClinicalTrials.gov